Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV5ch and AAV1
Key findings
Characterized Spark100 capsid engineering from AAVrh.74 template. Optimized for high liver transduction efficiency, favorable biodistribution profile, and reduced neutralizing antibody seroprevalence compared to AAV2 and AAV8.